Published in J Infect Dis on April 01, 1983
Varicella-zoster virus. Clin Microbiol Rev (1996) 3.03
Human monoclonal antibodies against a plethora of viral pathogens from single combinatorial libraries. Proc Natl Acad Sci U S A (1993) 2.01
Preventing varicella-zoster disease. Clin Microbiol Rev (2005) 1.55
Varicella zoster virus (VZV) in solid organ transplant recipients. Am J Transplant (2009) 1.02
Diagnosis and treatment of viral diseases in recipients of allogeneic hematopoietic stem cell transplantation. J Hematol Oncol (2013) 0.94
Approved Antiviral Drugs over the Past 50 Years. Clin Microbiol Rev (2016) 0.88
Comparison of two methods for detecting varicella-zoster virus antibody with varicella-zoster virus cell-mediated immunity. J Clin Microbiol (1996) 0.87
Relationship between preexisting anti-varicella-zoster virus (VZV) antibody and clinical VZV reactivation in hematopoietic stem cell transplantation recipients. J Clin Microbiol (2006) 0.85
Varicella zoster virus in solid organ transplantation. Am J Transplant (2013) 0.82
Pediatric human immunodeficiency virus infection. Clin Microbiol Rev (1996) 0.81
Aciclovir and varicella-zoster-immunoglobulin in solid-organ transplant recipients. Pediatr Nephrol (2010) 0.81
CD4 T cell responses in latent and chronic viral infections. Front Immunol (2013) 0.77
The non-immunosuppressive management of childhood nephrotic syndrome. Pediatr Nephrol (2015) 0.77
Chickenpox. BMJ Clin Evid (2007) 0.76
[Not Available]. Paediatr Child Health (2005) 0.75
Varicella-zoster virus hepatitis and a suggested management plan for prevention of VZV infection in adult liver transplant recipients. Transplantation (1995) 0.75
Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016. Ann Hematol (2016) 0.75
Varicella zoster immune globulin use in neonates and infants. Can J Infect Dis (1996) 0.75
Preventing congenital varicella syndrome with immunization. CMAJ (2011) 0.75
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med (2005) 17.06
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology (2010) 12.32
Homologous plant and bacterial proteins chaperone oligomeric protein assembly. Nature (1988) 9.55
Light-stimulated transcription of genes for two chloroplast polypeptides in isolated pea leaf nuclei. EMBO J (1982) 6.50
Protein synthesis in chloroplasts. I. Light-driven synthesis of the large subunit of fraction I protein by isolated pea chloroplasts. Biochim Biophys Acta (1973) 6.00
Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group. N Engl J Med (1993) 5.67
The HNRC 500--neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc (1995) 5.38
A new highly penetrant form of obesity due to deletions on chromosome 16p11.2. Nature (2010) 4.52
Ribozymes as potential anti-HIV-1 therapeutic agents. Science (1990) 4.49
Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy. Neurology (2009) 4.07
[Chloroplast ribosomes: stereospecificity of inhibition by chloramphenicol]. Science (1969) 3.89
A nondefective (competent) adenovirus-SV40 hybrid isolated from the AD.2-SV40 hybrid population. Proc Natl Acad Sci U S A (1969) 3.81
Measles antibody: reevaluation of protective titers. J Infect Dis (1990) 3.77
Rational strategy for rubella vaccination. Lancet (1983) 3.61
Growth inhibition by acycloguanosine of herpesviruses isolated from human infections. Antimicrob Agents Chemother (1979) 3.61
Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma. Gynecol Oncol (1998) 3.42
Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center. Ann Neurol (1997) 3.38
General occurrence and structural similarity of the rapidly synthesized, 32,000-dalton protein of the chloroplast membrane. J Biol Chem (1982) 3.34
Transport of proteins into chloroplasts. Partial purification of a chloroplast protease involved in the processing of important precursor polypeptides. Eur J Biochem (1984) 3.30
Light-stimulated accumulation of transcripts of nuclear and chloroplast genes for ribulosebisphosphate carboxylase. J Mol Appl Genet (1981) 3.28
A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group. N Engl J Med (1991) 3.05
Studies of nondefective adenovirus 2-simian virus 40 hybrid viruses. V. Isolation of additional hybrids which differ in their simian virus 40-specific biological properties. J Virol (1973) 2.87
A multimodal assessment of driving performance in HIV infection. Neurology (2004) 2.81
An unusual infection due to staphylococcus aureus. N Engl J Med (1971) 2.68
Antibody to varicella-zoster virus-induced membrane antigen: immunofluorescence assay using monodisperse glutaraldehyde-fixed target cells. J Infect Dis (1977) 2.65
Protein synthesis in chloroplasts. IX. Assembly of newly-synthesized large subunits into ribulose bisphosphate carboxylase in isolated intact pea chloroplasts. Biochim Biophys Acta (1980) 2.53
Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes. J Med Virol (1994) 2.50
Molecular chaperones: proteins essential for the biogenesis of some macromolecular structures. Trends Biochem Sci (1989) 2.48
Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis. Neurology (2002) 2.47
Patterns of transmission in measles outbreaks in the United States, 1985-1986. N Engl J Med (1989) 2.41
Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir. N Engl J Med (1982) 2.37
Atypical herpes simplex virus encephalitis diagnosed by PCR amplification of viral DNA from CSF. Neurology (1998) 2.26
Effects of macromolecular crowding on protein folding and aggregation. EMBO J (1999) 2.15
A persistent outbreak of measles despite appropriate prevention and control measures. Am J Epidemiol (1987) 2.13
Congenital rubella syndrome in the United States, 1970-1985. On the verge of elimination. Am J Epidemiol (1989) 2.12
Rapid detection of respiratory syncytial virus in nasopharyngeal secretions by enzyme-linked immunosorbent assay. J Clin Microbiol (1985) 2.10
Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation. Ann Intern Med (1983) 2.03
Studies of nondefective adenovirus 2-simian virus 40 hybrid viruses. VII. Characterization of the simian virus 40 RNA species induced by five nondefective hybrid viruses. J Virol (1973) 2.02
Virus-specific nucleic acids in SV40-exposed hamster embryo cell lines: correlation with S and T antigens. Proc Natl Acad Sci U S A (1969) 1.97
Transport of proteins into chloroplasts. The precursor of small subunit of ribulose bisphosphate carboxylase is processed to the mature size in two steps. Eur J Biochem (1984) 1.96
From the Center for Disease control: current status of measles in the United States, 1973--1977. J Infect Dis (1978) 1.91
Use of subgenomic poliovirus DNA hybridization probes to detect the major subgroups of enteroviruses. J Clin Microbiol (1984) 1.90
Acyclovir halts progression of herpes zoster in immunocompromised patients. N Engl J Med (1983) 1.90
A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment. Neurology (2007) 1.90
Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group. HIV Neurobehavioral Research Center. Brain Pathol (1999) 1.89
Preparation of vaccines for Rocky Mountain spotted fever from rickettsiae propagated in cell culture. J Infect Dis (1972) 1.88
Detection of parasite DNA in Chagas' heart disease. Lancet (1995) 1.86
Plasma polymerase chain reaction for cytomegalovirus DNA after allogeneic marrow transplantation: comparison with polymerase chain reaction using peripheral blood leukocytes, pp65 antigenemia, and viral culture. Transplantation (1997) 1.84
Resting cerebral blood flow: a potential biomarker of the effects of HIV in the brain. Neurology (2009) 1.83
Macromolecular crowding perturbs protein refolding kinetics: implications for folding inside the cell. EMBO J (2000) 1.81
Appropriate age for measles vaccination in the United States. Dev Biol Stand (1986) 1.80
Purification and properties of ribulosebisphosphate carboxylase large subunit binding protein. Plant Physiol (1986) 1.79
Direct detection of HIV-1 RNA from AIDS and ARC patient samples. DNA (1988) 1.79
Herpes simplex virus infection as a cause of benign recurrent lymphocytic meningitis. Ann Intern Med (1994) 1.77
Age-specific risks of varicella complications. Pediatrics (1981) 1.76
The impact of HIV-related neuropsychological dysfunction on driving behavior. The HNRC Group. J Int Neuropsychol Soc (1999) 1.75
Sites of synthesis of chloroplast proteins. Nature (1971) 1.75
Scleredema adultorum. Not always a benign self-limited disease. Arch Dermatol (1965) 1.73
Partial cardiopulmonary bypass, hypothermia, and total circulatory arrest. A lifesaving technique for ruptured mycotic aortic aneurysms, ruptured left ventricle, and other complicated cardiac pathology. J Thorac Cardiovasc Surg (1969) 1.73
Expression of small, therapeutic RNAs in human cell nuclei. Gene Ther (1997) 1.71
Current status of mumps and mumps vaccine in the United States. Pediatrics (1978) 1.71
Protein synthesis in chloroplasts. V. Translation of messenger RNA for the large subunit of fraction I protein in a heterologous cell-free system. J Mol Biol (1975) 1.70
Duration of live measles vaccine-induced immunity. Pediatr Infect Dis J (1990) 1.70
Herpes simplex virus type 1 DNA in cerebrospinal fluid of a patient with Mollaret's meningitis. N Engl J Med (1991) 1.69
Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy. J Virol (2005) 1.68
Neonatal enterovirus infection: virology, serology, and effects of intravenous immune globulin. Clin Infect Dis (1995) 1.66
Ammonium sulfate coprecipitation antibody determination with purified staphylococcal enterotoxins. J Bacteriol (1969) 1.66
Progressive cerebral volume loss in human immunodeficiency virus infection: a longitudinal volumetric magnetic resonance imaging study. HIV Neurobehavioral Research Center Group. Arch Neurol (1998) 1.66
Electronic properties, hydrogen bonding, stacking, and cation binding of DNA and RNA bases. Biopolymers (2002) 1.66
The biosynthesis of ribulose bisphosphate carboxylase. Uncoupling of the synthesis of the large and small subunits in isolated soybean leaf cells. Eur J Biochem (1979) 1.65
Epidemiology of pertussis, Atlanta, 1977. J Pediatr (1981) 1.62
ATP induces large quaternary rearrangements in a cage-like chaperonin structure. Curr Biol (1993) 1.62
Base-base and deoxyribose-base stacking interactions in B-DNA and Z-DNA: a quantum-chemical study. Biophys J (1997) 1.62
Specificity of the blastogenic response of human mononuclear cells to herpesvirus antigens. Infect Immun (1978) 1.60
Chaperone function: the assembly of ribulose bisphosphate carboxylase-oxygenase. Annu Rev Cell Biol (1990) 1.60
Protein synthesis in chloroplasts. Characteristics and products of protein synthesis in vitro in etioplasts and developing chloroplasts from pea leaves. Biochem J (1975) 1.60
Defining neurocognitive impairment in HIV: deficit scores versus clinical ratings. Clin Neuropsychol (2012) 1.60
Studies of nondefective adenovirus 2-simian virus 40 hybrid viruses. 3. Base composition, molecular weight, and conformation of the Ad2+ND genome. J Virol (1971) 1.59
Measles outbreak among unvaccinated preschool-aged children: opportunities missed by health care providers to administer measles vaccine. Pediatrics (1989) 1.57
Treatment and prevention of cytomegalovirus pneumonia after bone marrow transplantation: where do we stand? Blood (1994) 1.56
Site directed chromosomal marking of a fluorescent pseudomonad isolated from the phytosphere of sugar beet; stability and potential for marker gene transfer. Mol Ecol (1995) 1.55
Diagnosing symptomatic HIV-associated neurocognitive disorders: self-report versus performance-based assessment of everyday functioning. J Int Neuropsychol Soc (2011) 1.53
Rubella vaccination in the United States: a ten-year review. Epidemiol Rev (1980) 1.53
Indinavir population pharmacokinetics in plasma and cerebrospinal fluid. The HIV Neurobehavioral Research Center Group. Antimicrob Agents Chemother (2000) 1.52
Sulphur metabolism: the usefulness of N-ethylmaleimide. Nature (1966) 1.51
Fetal risk associated with rubella vaccine: an update. Rev Infect Dis (1985) 1.50
Functional analysis of the intergenic regions of TcP2beta gene loci allowed the construction of an improved Trypanosoma cruzi expression vector. Gene (1999) 1.50
Molecular karyotype of clone CL Brener chosen for the Trypanosoma cruzi genome project. Mol Biochem Parasitol (1995) 1.48
Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder. Neurology (2012) 1.48
Factors affecting the detection of enteroviruses in cerebrospinal fluid with coxsackievirus B3 and poliovirus 1 cDNA probes. J Clin Microbiol (1985) 1.47
Protein synthesis in chloroplasts. VIII. Differential synthesis of chloroplast proteins during spinach leaf development. Biochim Biophys Acta (1980) 1.46
Immune response to herpesvirus antigens in adults with acute cytomegaloviral mononucleosis. J Infect Dis (1979) 1.46